Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-03 Yoo Stephen Chief Medical Officer Grant or award · Stock Option (Right to Buy) +55,000 55,000
2018-01-03 Danos Olivier Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +41,250 41,250
2018-01-03 Vasista Vittal Chief Financial Officer Grant or award · Stock Option (Right to Buy) +55,000 55,000
2018-01-03 Mills Kenneth T. President and CEO Grant or award · Stock Option (Right to Buy) +163,500 163,500
2017-12-29 Christmas Patrick J. SVP, General Counsel Grant or award +486 $17.43 $8K 1,141
2017-12-22 Simpson Curran SVP, Technical Operations Exercise or conversion +30,000 $22.00 $660K 69,500
2017-12-22 Simpson Curran SVP, Technical Operations Sale −30,000 $33.03 $991K 39,500
2017-12-22 Simpson Curran SVP, Technical Operations Exercise or conversion · Stock Option (Right to Buy) −30,000 180,500
2017-12-20 Mills Kenneth T. President and CEO Sale −10,000 $31.75 $318K 108,530
2017-12-19 Vasista Vittal Chief Financial Officer Sale −4,994 $30.00 $150K 82,283
2017-12-18 Vasista Vittal Chief Financial Officer Sale −6 $30.00 $180 87,277
2017-12-07 Simpson Curran SVP, Technical Operations Exercise or conversion +1,890 $13.09 $25K 41,390
2017-12-07 Simpson Curran SVP, Technical Operations Exercise or conversion +20,000 $22.00 $440K 61,390
2017-12-07 Simpson Curran SVP, Technical Operations Sale −21,890 $30.04 $658K 39,500
2017-12-07 Simpson Curran SVP, Technical Operations Exercise or conversion · Stock Option (Right to Buy) −1,890 6,000
2017-12-07 Simpson Curran SVP, Technical Operations Exercise or conversion · Stock Option (Right to Buy) −20,000 210,500
2017-12-04 Simpson Curran SVP, Technical Operations Exercise or conversion +110 $13.09 $1K 39,610
2017-12-04 Simpson Curran SVP, Technical Operations Sale −110 $30.00 $3K 39,500
2017-12-04 Simpson Curran SVP, Technical Operations Exercise or conversion · Stock Option (Right to Buy) −110 7,890
2017-11-27 Simpson Curran SVP, Technical Operations Exercise or conversion +2,000 $13.09 $26K 41,500

Page 44 of 56 · 1,104 trades